Chapter 55: Anemia Drugs – Iron, Folic Acid & Erythropoiesis Agents

The study of anemia drugs focuses on the foundational biological processes of hematopoiesis and erythropoiesis, detailing how deficiencies in essential nutrients—specifically iron, vitamin B12 (cyanocobalamin), and folic acid (B9)—can impair blood cell production and lead to various types of anemia. Anemias are classified based on underlying causes, such as cytoplasmic maturation defects, which often result in microcytic and hypochromic red blood cells (RBCs) seen in iron-deficiency anemia, or nuclear maturation defects, which cause macrocytic RBCs characteristic of megaloblastic anemias stemming from B12 or folate shortages necessary for DNA synthesis. The chapter covers therapeutic agents used to correct these imbalances. Erythropoiesis-stimulating agents (ESAs), such as epoetin alfa, are synthetic hormones that stimulate RBC production and are critical for treating anemia associated with end-stage kidney disease or chemotherapy; however, their administration requires careful monitoring of hypertension and hemoglobin levels, as exceeding target ranges significantly increases the risk of serious adverse cardiovascular events. Iron supplements, available in various oral ferrous salt forms (like ferrous fumarate) and injectable complexes, are crucial for hemoglobin formation, but nurses must manage common adverse effects like GI upset and constipation, while recognizing that iron overdose is a serious pediatric poisoning risk. Finally, folic acid supplementation is vital for healthy erythropoiesis and the prevention of neural tube anomalies during pregnancy, but its use is strictly contraindicated until pernicious anemia (B12 deficiency) is definitively ruled out, as folate can deceptively mask the serious neurological deterioration caused by a lack of vitamin B12. The nursing process for these drugs emphasizes comprehensive patient assessment, monitoring for drug-specific side effects, and meticulous administration techniques, especially regarding drug interactions that impact absorption (e.g., taking iron with orange juice but avoiding antacids or milk).